| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
25,750,000 |
| Market
Cap: |
461.44(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.1 - $22.08 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 14.6 |
| Insider 6 Months : 14.6 |
| Insider 3/6 Months : 29.5 |
|
| Guru Rank Number : 140 |
| Guru Rank Value : 7.2 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Harrow Health engages in the development, production and sale of medications. Co. owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical businesses. Through its subsidiaries, Visionology, Inc., which provides an online eye health platform; Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
179,000 |
179,000 |
257,300 |
699,568 |
| Total Buy Value |
$1,948,031 |
$1,948,031 |
$2,938,957 |
$7,583,356 |
| Total People Bought |
2 |
2 |
3 |
3 |
| Total Buy Transactions |
7 |
7 |
13 |
15 |
| Total Shares Sold |
0 |
0 |
0 |
40,000 |
| Total Sell Value |
$0 |
$0 |
$0 |
$504,800 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kammer Robert J |
Director |
– • • |
2015-04-23 |
4 |
OE |
$5.93 |
$90,546 |
D/D |
15,282 |
988,546 |
|
- |
|
| Boll Andrew |
Chief Financial Officer |
• – – |
2015-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
187,500 |
187,500 |
|
- |
|
| Saharek John P. |
Chief Commercial Officer |
• – – |
2015-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
| Kammer Robert J |
Director |
– • • |
2014-09-30 |
4 |
D |
$7.42 |
$323,438 |
D/D |
(43,590) |
973,264 |
|
- |
|
| Kammer Robert J |
Director |
– • • |
2014-09-30 |
4 |
OE |
$4.50 |
$323,438 |
D/D |
71,875 |
1,001,692 |
|
- |
|
| Bassani August Shelby |
Director |
– • – |
2014-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,623 |
13,488 |
|
- |
|
| Kammer Robert J |
Director |
– • • |
2014-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,623 |
944,979 |
|
- |
|
| Austin Stephen G |
Director |
– • – |
2014-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,623 |
13,488 |
|
- |
|
| Nelson William H. |
Director |
– • – |
2014-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,623 |
6,623 |
|
- |
|
134 Records found
|
|
Page 6 of 6 |
|
|
0.51 (2.93%) 
